Wordt geladen...
Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus
BACKGROUND: The effectiveness of neoadjuvant treatment (NT) prior to resection of squamous cell carcinoma of the esophagus (SCCE) in terms of prolonged survival has not been proven by randomized trials. Facing considerable financial expenses and with concerns regarding the consumption of the patient...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2001
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC61000/ https://ncbi.nlm.nih.gov/pubmed/11737874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-1-20 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|